GSK Tries To Chase Down Pfizer With Phase III Pentavalent Meningococcal Vaccine Data

 
• By Joseph Haas
  
GSK Exit
GSK's pentavalent meningococcal vaccine hits its Phase III endpoints • Source: Shutterstock

More from Clinical Trials

More from R&D